M

MoonLake Immunotherapeutics
D

MLTX

43.560
USD
0.49
(1.14%)
مغلق
حجم التداول
13,185
الربح لكل سهم
-3
العائد الربحي
-
P/E
-19
حجم السوق
2,764,938,461
أصول ذات صلة
ALC
ALC
-0.160
(-0.19%)
84.730 USD
FAST
FAST
-0.060
(-0.14%)
41.485 USD
L
LX
-0.02500
(-0.35%)
7.06000 USD
STX
STX
0.440
(0.34%)
131.310 USD
المزيد
الأخبار المقالات

العنوان: MoonLake Immunotherapeutics

القطاع: Healthcare
الصناعة: Biotechnology
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.